Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis

Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis

For the first time, a novel aptamer was designed and utilized for the selective detection of rivaroxaban (RIV) using the integration of bioinformatics with biosensing technology. The selected aptamer with the sequence 5′-TAG GGA AGA GAA GGA CAT ATG ATG ACT CAC AAC TGG ACG AAC GTA CTT ATC CCC CCC AAT...

Full description

Bibliographic Details
Main Authors: Rokhsareh Ebrahimi, Abolfazl Barzegari, Reza Teimuri-Mofrad, Houman Kholafazad Kordasht, Mohammad Hasanzadeh, Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Abbas Afrasiabi Rad, Nasrin Shadjou, Mohammad-Reza Rashidi, Mohammad Reza Afshar Mogaddam, Abolghasem Jouyban
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biosensors
Subjects:
rivaroxaban
aptamer
aptasensor
bioanalysis of drugs
biotechnology
advanced nanomaterial
Online Access:https://www.mdpi.com/2079-6374/12/10/773

Internet

https://www.mdpi.com/2079-6374/12/10/773

Similar Items